A recent study found that grape seed extract outperforms a popular diabetes drug known as metformin at lowering elevated blood sugar and insulin.
In the study, rats were prescribed a high fat, high sugar diet designed specifically to encourage insulin resistance, and while the results indicated that both MET and grape seed extract reduced high blood sugar levels and elevated blood insulin, grape seed extract was superior in one specific way.
“Clearly, the weight of evidence suggests that grape seed proanthrocyanins hold great promise as a metformin alternative and/or anti-diabetic agent. Unfortunately, the law forbids the medicinal use of natural substances, and lacking the $800 million plus required on average to fund the clinical trials necessary to file for FDA drug approval, health consumers are left almost entirely without guidance from conventional medical practitioners who lose their FDA-underwritten liability shield when they deviate from the drug-based standard of care”.
This is far from the first study to link grape seeds and beneficial health outcomes. Just last month we reported on a study from the University of Colorado Cancer Center which found grapeseed extract to prohibit cancer cell growth while promoting cancer cell death. Most interesting, that “it required less than half the concentration of GSE to suppress cell growth and kill 50% of stage IV cells than it did to achieve similar results in the state II cells.”